NYSE:LLY - Eli Lilly And Co Stock Price, Forecast & News

Eli Lilly And Co's stock was trading at $140.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LLY stock has increased by 1.5% and is now trading at $142.18. View which stocks have been mosted impacted by Coronavirus.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eli Lilly And Co in the last year. There are currently 2 hold ratings, 9 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Eli Lilly And Co.

Eli Lilly And Co is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for Eli Lilly And Co.

Eli Lilly And Co will be holding an earnings conference call on Thursday, April 23rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Eli Lilly And Co (NYSE:LLY) posted its quarterly earnings data on Thursday, January, 30th. The company reported $1.73 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.21. The firm had revenue of $6.11 billion for the quarter, compared to analyst estimates of $5.92 billion. Eli Lilly And Co had a net margin of 37.27% and a return on equity of 192.27%. The business's quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.33 EPS. View Eli Lilly And Co's earnings history.

Eli Lilly And Co announced a quarterly dividend on Monday, December 16th. Shareholders of record on Friday, February 14th will be given a dividend of $0.74 per share on Tuesday, March 10th. This represents a $2.96 annualized dividend and a yield of 2.08%. The ex-dividend date of this dividend is Thursday, February 13th. This is a positive change from Eli Lilly And Co's previous quarterly dividend of $0.65. View Eli Lilly And Co's dividend history.

Eli Lilly And Co updated its FY20 earnings guidance on Thursday, January, 30th. The company provided earnings per share (EPS) guidance of $6.70-6.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.76. The company issued revenue guidance of $23.7-24.2 billion, compared to the consensus revenue estimate of $23.78 billion.

12 equities research analysts have issued 12-month price objectives for Eli Lilly And Co's stock. Their forecasts range from $117.49 to $168.00. On average, they expect Eli Lilly And Co's share price to reach $143.11 in the next twelve months. This suggests a possible upside of 0.7% from the stock's current price. View analysts' price targets for Eli Lilly And Co.

News headlines about LLY stock have trended very negative on Thursday, InfoTrie reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Eli Lilly And Co earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutEli Lilly And Co.

Eli Lilly And Co saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 10,890,000 shares, a decline of 11.1% from the February 13th total of 12,250,000 shares. Based on an average daily trading volume, of 3,940,000 shares, the days-to-cover ratio is presently 2.8 days. Currently, 1.3% of the company's shares are short sold. View Eli Lilly And Co's Current Options Chain.

Some companies that are related to Eli Lilly And Co include Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol-Myers Squibb (BMY), AbbVie (ABBV), Allergan (AGN), Zoetis (ZTS), Mylan (MYL), Perrigo (PRGO), Horizon Therapeutics (HZNP), Jazz Pharmaceuticals (JAZZ), Nektar Therapeutics (NKTR), Pacira Biosciences (PCRX), Corcept Therapeutics (CORT) and Zogenix (ZGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Eli Lilly And Co investors own include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), AT&T (T), Intel (INTC), Bristol-Myers Squibb (BMY), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Verizon Communications (VZ) and Bank of America (BAC).

Eli Lilly And Co trades on the New York Stock Exchange (NYSE) under the ticker symbol "LLY."

Eli Lilly And Co's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Park National Corp OH (0.00%), Cullinan Associates Inc. (0.00%), Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%) and First Financial Bank Trust Division (0.00%). Company insiders that own Eli Lilly And Co stock include Aarti S Shah, Alfonso G Zulueta, Anne E White, Christi Shaw, Daniel Skovronsky, David A Ricks, Donald A Zakrowski, Eli & Co Lilly, Enrique A Conterno, Jackson P Tai, Jeffrey N Simmons, Joshua L Smiley, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, Stephen F Fry and Susan Mahony. View institutional ownership trends for Eli Lilly And Co.

LLY stock was sold by a variety of institutional investors in the last quarter, including Cullinan Associates Inc., Park National Corp OH, Nelson Van Denburg & Campbell Wealth Management Group LLC, and First Financial Bank Trust Division. Company insiders that have sold Eli Lilly And Co company stock in the last year include Aarti S Shah, Alfonso G Zulueta, Christi Shaw, Lilly Endowment Inc, Melissa S Barnes, Michael J Harrington, Myles O'neill, and Stephen F Fry. View insider buying and selling activity for Eli Lilly And Co.

Shares of LLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of LLY stock can currently be purchased for approximately $142.18.

Eli Lilly And Co has a market capitalization of $136.07 billion and generates $22.32 billion in revenue each year. The company earns $8.32 billion in net income (profit) each year or $6.04 on an earnings per share basis. Eli Lilly And Co employs 33,625 workers across the globe. View additional information about Eli Lilly And Co.

The official website for Eli Lilly And Co is http://www.lilly.com/.

Eli Lilly And Co's mailing address is LILLY CORPORATE CENTER, INDIANAPOLIS IN, 46285. The company can be reached via phone at 317-276-2000 or via email at [email protected]